Products

Shire is now part of Takeda.

The current Takeda Products Ireland Ltd portfolio comprises of the following medicines.

To download a patient information leaflet (PIL) and a summary of product characteristics (SmPC) for each medicine, simply follow the links within the table below.

If you are a member of the public requiring advice or information on your own medical condition or treatment listed below please consult your General Practitioner or other healthcare professional in the first instance.

BUCCOLAM 2.5 mg, 5 mg, 7.5 mg and 10 mg Oromucosal Solution Alert

Please click here for information and guidance for healthcare professionals regarding the Buccolam tip-cap issue and correct use of the product.

Name

Summary of Product Characteristics Patient Information Leaflet

Actos 15 mg, 30 mg, 45 mg tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Adcetris 50 mg powder for concentrate for solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

ADVATE 250 IU, 500 IU, 1000 IU and 1500 IU powder and solvent for solution for injection 2 ml solvent - Baxject III

Summary of product characteristics SmPC Patient Information leaflet PIL

ADVATE 2000 IU and 3000 IU powder and solvent for solution for injection 5 ml water - Baxject III 

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Alofisel 5 million cells/mL suspension for injection

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Alunbrig 30 mg, 90 mg, 180 mg film-coated tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Blopress tablets 2mg, 4mg, 8mg, 16mg, 32mg

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Blopress Plus 8 mg/12.5 mg, 16 mg/12.5 mg, 32 mg/12.5 mg, 32 mg/25 mg

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Buccolam 2.5mg, 5mg, 7.5mg and 10mg oromucosal solution

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Calcichew 500 mg chewable tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Calcichew D3 Forte chewable tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Calcichew D3 Forte double strength 1000 mg/800 IU chewable tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

CEPROTIN 1000 IU powder and solvent for solution for injection

Summary of product characteristics SmPC Patient Information leaflet PIL

CEPROTIN 500 IU powder and solvent for solution for injection

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Cinryze 500 IU powder and solvent for solution for injection

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Competact 15 mg/850 mg film-coated tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Condyline cutaneous solution 0.5 % w/v

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Cuvitru 200 mg/ml solution for subcutaneous injection

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Edarbi 20 mg, 40 mg, 80 mg tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Entyvio 300 mg powder for concentrate for solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Elaprase 2 mg/ml concentrate for solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Equasym XL 10, 20 & 30mg Modified Release Capsules

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

FEIBA 25 U/ml powder and solvent for solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

FEIBA 50 U/ml powder and solvent for solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Firazyr 30 mg solution for injection in pre-filled syringe

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Flexbumin 200 g/l solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Foznol 250mg, 500mg, 750mg & 1000mg Chewable Tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

GAMMAGARD S/D Human Normal Immunoglobulin for Intravenous Administration Powder and solvent for solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Human Albumin Baxalta 50 g/l Solution for Infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

HyQvia 100 mg/ml solution for infusion for subcutaneous use

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Instanyl 50, 100 and 200 mcg nasal spray, solution in single-dose container

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Intuniv 1mg, 2mg, 3mg, 4mg prolonged-release tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Kiovig 100 mg/ml solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Matrifen transdermal patch

12 micrograms/hour, 25 micrograms/hour, 50 micrograms/hour, 75 micrograms/hour, 100 micrograms/hour 

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Mepact 4 mg powder for suspension for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Mezavant XL 1200mg, gastro-resistant, prolonged release tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Midon 2.5 mg tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Midon 5 mg tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Ninlaro 2.3 mg, 3 mg, 4 mg hard capsules

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Obizur 500 U powder and solvent for solution for injection

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Prothromplex TOTAL 600 IU powder and solvent for solution for injection

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Reminyl Oral Solution

Summary of product characteristics SmPC Patient Information leaflet PIL

Reminyl XL 8mg, 16mg and 24 mg prolonged release capsules

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Replagal 1 mg/ml concentrate for solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Resolor 1 mg film-coated tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Resolor 2 mg film-coated tablets

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Revestive 1.25 mg powder and solvent for solution for injection

Summary of product characteristics SmPC Patient Information leaflet PIL

Revestive 5 mg powder and solvent for solution for injection

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Tyvense 20mg, 30mg, 40mg, 50mg. 60mg & 70mg Capsules, hard

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Tachosil sealant matrix

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

VEYVONDI 650 IU and 1300 IU powder and solvent for solution for injection

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Vpriv 400 Units powder for solution for infusion

Summary of product characteristics SmPC Patient Information leaflet PIL

Name

Summary of Product Characteristics Patient Information Leaflet

Xagrid 0.5mg hard capsule

Summary of product characteristics SmPC Patient Information leaflet PIL

 

 

The black triangle denotes this medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Information about Adverse Event reporting can be found on the HPRA website www.hpra.ie.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report Adverse Events directly to HPRA Pharmacovigilance, Website: www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.

Adverse events should also be reported to Takeda Products Ireland Ltd:

Legacy-Takeda products: DSO-UK@takeda.com
Legacy-Shire products:  drugsafety@shire.com

 

Medical Information

Our medical information service is intended to provide information on our products to Healthcare Professionals.  For contact information, please view our Contact us page

 

IRE/WBC/18/0008c(3)

Date of Preparation: June 2020